admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Levitee Labs Appoints Dr. Mohammed Mosli as Chief People Officer of...

MYND Diagnostics Inc. Announces Participation in a Monash University (Australia) Proposal...

Numinus Upgrades Psychedelics Lab to Increase Research Service Capabilities

PT266 – Jerry B. Brown, Ph.D. – Psychedelics: Past, Present, and...

atai Life Sciences announces the launch of PsyProtix, to develop a...

PTSF80 – Decriminalization in Seattle, San Pedro, and The Dark Web

Psyched Wellness Announces Commencement of Next Pre-Clinical Study on AME-1

Tryp Therapeutics Announces Collaboration with Researchers at the University of Wisconsin-Madison

MYND Life Sciences Announces Diagnostic Division with Formation of Wholly-Owned Subsidiary...

Psygen Announces use of Psilocybin in Human Trial and Provides Update...

1...190191192...218 Page 191 of 218

EDITOR PICKS

The Interdisciplinary Annotated Psychedelic Research Bibliography of 2024

Reflections on the 2025 Federal Policy Summit on Psychedelic Medicine

Spring 2025 Psychedelic Policy Update: Bills Hang in the Balance as...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin